HotStix Stock of the Week – Sinobiomed Inc. (SOBM.OB)
Sinobiomed Inc. (SOBM.OB) is a leading Chinese developer of genetically engineered recombinant protein drugs and vaccines. Sinobiomed employs a patented, low-cost, high-yield production process to enhance bioactivity and guarantee the highest levels of purity. Sinobiomed currently has 10 products approved or in development: three on the market, four in clinical trials, and three in R&D. The company's products respond to a wide range of diseases and conditions, including hepatitis B&C, surgical bleeding, diabetic ulcers and burns, malaria, cancer, rheumatoid arthritis, acute liver disease, stroke, blood clots and thrombosis, acute pancreatitis, and blood cell regeneration. Sinobiomed has several competitive advantages in…